Literature DB >> 28802838

Identification of immune correlates of protection in Shigella infection by application of machine learning.

Jorge M Arevalillo1, Marcelo B Sztein2, Karen L Kotloff3, Myron M Levine4, Jakub K Simon5.   

Abstract

BACKGROUND: Immunologic correlates of protection are important in vaccine development because they give insight into mechanisms of protection, assist in the identification of promising vaccine candidates, and serve as endpoints in bridging clinical vaccine studies. Our goal is the development of a methodology to identify immunologic correlates of protection using the Shigella challenge as a model.
METHODS: The proposed methodology utilizes the Random Forests (RF) machine learning algorithm as well as Classification and Regression Trees (CART) to detect immune markers that predict protection, identify interactions between variables, and define optimal cutoffs. Logistic regression modeling is applied to estimate the probability of protection and the confidence interval (CI) for such a probability is computed by bootstrapping the logistic regression models.
RESULTS: The results demonstrate that the combination of Classification and Regression Trees and Random Forests complements the standard logistic regression and uncovers subtle immune interactions. Specific levels of immunoglobulin IgG antibody in blood on the day of challenge predicted protection in 75% (95% CI 67-86). Of those subjects that did not have blood IgG at or above a defined threshold, 100% were protected if they had IgA antibody secreting cells above a defined threshold. Comparison with the results obtained by applying only logistic regression modeling with standard Akaike Information Criterion for model selection shows the usefulness of the proposed method.
CONCLUSION: Given the complexity of the immune system, the use of machine learning methods may enhance traditional statistical approaches. When applied together, they offer a novel way to quantify important immune correlates of protection that may help the development of vaccines.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification and Regression Trees; Correlate of protection; Logistic regression; Random Forests algorithm; Shigella

Mesh:

Substances:

Year:  2017        PMID: 28802838      PMCID: PMC5641263          DOI: 10.1016/j.jbi.2017.08.005

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  37 in total

Review 1.  Development, acceptance, and use of immunologic correlates of protection in monitoring the effectiveness of combination vaccines.

Authors:  K M Edwards
Journal:  Clin Infect Dis       Date:  2001-12-15       Impact factor: 9.079

Review 2.  Stable feature selection for biomarker discovery.

Authors:  Zengyou He; Weichuan Yu
Journal:  Comput Biol Chem       Date:  2010-08-10       Impact factor: 2.877

3.  A screening methodology based on Random Forests to improve the detection of gene-gene interactions.

Authors:  Lizzy De Lobel; Pierre Geurts; Guy Baele; Francesc Castro-Giner; Manolis Kogevinas; Kristel Van Steen
Journal:  Eur J Hum Genet       Date:  2010-05-12       Impact factor: 4.246

Review 4.  Dissection of cytotoxic and helper T cell responses.

Authors:  K Schepers; R Arens; T N M Schumacher
Journal:  Cell Mol Life Sci       Date:  2005-12       Impact factor: 9.261

Review 5.  Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT.

Authors:  R Shouval; O Bondi; H Mishan; A Shimoni; R Unger; A Nagler
Journal:  Bone Marrow Transplant       Date:  2013-10-07       Impact factor: 5.483

Review 6.  New and candidate vaccines for gastrointestinal infections.

Authors:  Jakub Simon; Karen Kotloff
Journal:  Curr Opin Gastroenterol       Date:  2010-01       Impact factor: 3.287

7.  Exploring serological classification tree model of active pulmonary tuberculosis by magnetic beads pretreatment and MALDI-TOF MS analysis.

Authors:  C Deng; M Lin; C Hu; Y Li; Y Gao; X Cheng; F Zhang; M Dong; Y Li
Journal:  Scand J Immunol       Date:  2011-10       Impact factor: 3.487

8.  Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009.

Authors:  Peng-jun Lu; Kathy K Byrd; Trudy V Murphy; Cindy Weinbaum
Journal:  Vaccine       Date:  2011-07-22       Impact factor: 3.641

9.  Profiling and classification tree applied to renal epithelial tumours.

Authors:  Y Allory; C Bazille; A Vieillefond; V Molinié; B Cochand-Priollet; O Cussenot; P Callard; M Sibony
Journal:  Histopathology       Date:  2007-11-22       Impact factor: 5.087

10.  Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.

Authors:  K L Kotloff; G A Losonsky; J P Nataro; S S Wasserman; T L Hale; D N Taylor; J W Newland; J C Sadoff; S B Formal; M M Levine
Journal:  Vaccine       Date:  1995-04       Impact factor: 3.641

View more
  9 in total

Review 1.  Leveraging Computational Modeling to Understand Infectious Diseases.

Authors:  Adrianne L Jenner; Rosemary A Aogo; Courtney L Davis; Amber M Smith; Morgan Craig
Journal:  Curr Pathobiol Rep       Date:  2020-09-24

Review 2.  Transcriptomics in Human Challenge Models.

Authors:  Amber J Barton; Jennifer Hill; Andrew J Pollard; Christoph J Blohmke
Journal:  Front Immunol       Date:  2017-12-18       Impact factor: 7.561

Review 3.  Novel Strategies for Malaria Vaccine Design.

Authors:  Augustina Frimpong; Kwadwo Asamoah Kusi; Michael Fokuo Ofori; Wilfred Ndifon
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

Review 4.  Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella.

Authors:  Esther Ndungo; Marcela F Pasetti
Journal:  Hum Vaccin Immunother       Date:  2019-08-01       Impact factor: 3.452

5.  RV144 HIV-1 vaccination impacts post-infection antibody responses.

Authors:  Thembi Mdluli; Ningbo Jian; Bonnie Slike; Dominic Paquin-Proulx; Gina Donofrio; Aljawharah Alrubayyi; Syna Gift; Rebecca Grande; Mary Bryson; Anna Lee; Vincent Dussupt; Letzibeth Mendez-Riveria; Eric Sanders-Buell; Agnès-Laurence Chenine; Ursula Tran; Yifan Li; Eric Brown; Paul T Edlefsen; Robert O'Connell; Peter Gilbert; Sorachai Nitayaphan; Punnee Pitisuttihum; Supachai Rerks-Ngarm; Merlin L Robb; Robert Gramzinski; Galit Alter; Sodsai Tovanabutra; Ivelin S Georgiev; Margaret E Ackerman; Victoria R Polonis; Sandhya Vasan; Nelson L Michael; Jerome H Kim; Michael A Eller; Shelly J Krebs; Morgane Rolland
Journal:  PLoS Pathog       Date:  2020-12-08       Impact factor: 6.823

Review 6.  A Study of the Recent Trends of Immunology: Key Challenges, Domains, Applications, Datasets, and Future Directions.

Authors:  Sharnil Pandya; Aanchal Thakur; Santosh Saxena; Nandita Jassal; Chirag Patel; Kirit Modi; Pooja Shah; Rahul Joshi; Sudhanshu Gonge; Kalyani Kadam; Prachi Kadam
Journal:  Sensors (Basel)       Date:  2021-11-23       Impact factor: 3.576

7.  Systems approach to define humoral correlates of immunity to Shigella.

Authors:  Biana Bernshtein; Esther Ndungo; Deniz Cizmeci; Peng Xu; Pavol Kováč; Meagan Kelly; Dilara Islam; Edward T Ryan; Karen L Kotloff; Marcela F Pasetti; Galit Alter
Journal:  Cell Rep       Date:  2022-08-16       Impact factor: 9.995

8.  Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G.

Authors:  Kristen A Clarkson; Robert W Frenck; Michelle Dickey; Akamol E Suvarnapunya; Lakshmi Chandrasekaran; Hailey P Weerts; Christopher D Heaney; Monica McNeal; Kate Detizio; Susan Parker; Amy Hoeper; August L Bourgeois; Chad K Porter; Malabi M Venkatesan; Robert W Kaminski
Journal:  mSphere       Date:  2020-09-23       Impact factor: 4.389

9.  Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei.

Authors:  Kristen A Clarkson; Chad K Porter; Kawsar R Talaat; Robert W Frenck; Cristina Alaimo; Patricia Martin; A Louis Bourgeois; Robert W Kaminski
Journal:  mSphere       Date:  2021-07-14       Impact factor: 4.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.